Hydrogen peroxide induces-loss of dopamine transporter activity: A calcium-dependent oxidative mechanism

Journal of Neurochemistry

Volumn 86, Issue 5, 2003, Pages 1247-1259

  Huang, Chuen Lin ^a,b   Huang, Nai Kuei ^c   Shyue, Song Kun ^a   Chem, Yijuang ^a,b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Calcium; Dopamine transporter; Hydrogen peroxide; Hydroxyl radicals; PC12; Reactive oxygen species

Indexed keywords

CALCIUM; CATALASE; CONCANAVALIN A; CUMENE; DITHIODIPYRIDINE; DOPAMINE TRANSPORTER; HYDROGEN PEROXIDE; OXIDIZING AGENT; THAPSIGARGIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; ENDOCYTOSIS; EXTRACELLULAR SPACE; GENE OVEREXPRESSION; INTERNALIZATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REDUCTION; SENSOR; SYNAPTOSOME;

ANIMALIA;

EID: 0041430627     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01936.x     Document Type: Article

References (64)

1. 2+ channels present in synaptosomes from rat and chicken central nervous system. J. Neurochem. 64, 2544-2551.
2. Bae S. Y., Kang S. W., Seo M. S., Banies I. C., Tekle E., Chock P. B. and Rhee S. G. (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217-221.
3. Bass D. A., J. W. Parce L. R., Dechatelet P., Szejda M. C., Seeds and Thomas M. (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130, 1910-1917.
4. Batchelor M. and Schenk J. O. (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18, 10304-10309.
5. Berger S. P., Farrell K., Conant D., Kempner E. S. and Paul S. M. (1994) Radiation inactivation studies of the dopamine reuptake transporter protein. Mol. Pharmacol. 46, 726-731.
6. Berman S. B., Zigmond M. J. and Hastings T. G. (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593-600.
7. Bielefeldt K., Whiteis C. A., Sharma R. V., Abboud F. M. and Conklin J. L. (1997) Reactive oxygen species and calcium homeostasis in cultured human intestinal smooth muscle cells. Am. J. Physiol. 272, G1439-G1450.
8. Britigan B. E., Rasmussen G. T. and Cox C. D. (1998) Binding of iron and inhibition of iron-dependent oxidative cell injury by the 'calcium chelator' 1,2-bis (2-aminophenoxy) ethane N,N,N′,N′-tetraacetic acid (BAPTA). Biochem. Pharmacol. 55, 287-295.
9. 2+ in isolated skeletal muscle. Proc. Natl Acad. Sci. USA 96, 3281-3286.
10. Cameiro A. M., Ingram S. L., Beaulieu J. M., Sweeney A., Amara S. G., Thomas S. M., Caron M. G. and Torres G. E. (2002) The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J. Neurosci. 22, 7045-7054.
11. Carvelli L., Moron J. A., Kahlig K. M., Ferrer J. V., Sen N., Lechleiter J. D., Leeb-Lundberg L. M. F., Merrill G., Lafer E. M., Ballou L. M., Shippenberg T. S., Javitch J. A., Lin R. Z. and Galli A. (2002) PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81, 859-869.
12. Chen J. G. and Rudnick G. (2000) Permeation and gating residues in serotonin transporter. Proc. Natl Acad. Sci. U S A. 97, 1044-1049.
13. Chen N., Ferrer J. V., Javitch J. A. and Justice J. B. Jr (2000) Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter. J. Biol. Chem. 275, 1608-1614.
14. Chem Y., Lai H.-L., Fong J.-C. and Liang Y. (1993) Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol. Pharmacol. 44, 950-958.
15. + channels. Circ. Res. 76, 325-334.
16. Copeland B. J., Volgelsberg V., Neff N. H. and Hadjiconstantinou M. (1996) Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther 277, 1527-1532.
17. Daniels G. M. and Amara S. G. (1999) Regulated trafficking of the human dopamine transporter: clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 35794-35801.
18. Ebadi M., Srinivasan S. K. and Baxi M. D. (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48, 1-19.
19. Ferrer J. V. and Javitch J. A. (1998) Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proc. Natl Acad. Sci. USA 95, 9238-9243.
20. Fumagalli F., Gainetdinov R. R., Valenzano K. J. and Caron M. G. (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18, 4861-4869.
21. Gainetdinov R. R., Fumagalli F., Jones S. R. and Caron M. G. (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J. Neurochem. 69, 1322-1325.
22. Giros B. and Caron M. G. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49.
23. Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
24. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
25. Hastrup H., Karlin A. and Javitch J. A. (2001) Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl Acad. Sci. USA 98, 10055-10060.
26. Haugeto O., Ullensvang K., Levy L. M., Chaudhry F. A., Honore T., Nielsen M., Lehre K. P. and Danbolt N. C. (1996) Brain glutamate transporter proteins form homodimers. J. Biol. Chem. 271, 27715-27722.
27. Herson P. S., Lee K., Pinnock R. D., Hughes J. and Ashford M. L. J. (1999) Hydrogen peroxide induces intracellular calcium overload by activation of a non-selective cation channel in an insulin-secreting cell line. J. Biol. Chem. 274, 833-841.
28. Huang C.-L., Chen H.-C., Huang N.-K., Yang D.-M., Kao L.-S., Chen J.-C., Lai H.-L. and Chem Y. (1999) Modulation of dopamine transporter activity by nicotinic acetylcholine receptors and membrane depolarization in rat pheochromocytoma PC12 cells. J. Neurochem. 72, 2437-2444.
29. Huang N.-K., Wan F. J., Tseng C. J. and Tung C. S. (1997) Amphetamine induces hydroxyl radical formation in the striatum of rats. Life Sci. 61, 2219-2229.
30. Huff R. A., Vaughn R. A., Kuhar M. J. and Uhl G. R. (1997) Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax. J. Neurochem. 68, 225-232.
31. 2 in vitro. Brain Res. 671, 181-186.
32. Inoue M., Sakaguchi N., Isuzugawa K., Tani H. and Ogihara Y. (2000) Role of reactive oxygen species in gallic acid-induced apoptosis. Biol. Pharm. Bull. 23, 1153-1157.
33. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
34. Lee F. J. S., Liu F., Pristupa Z. B. and Niznik H. B. (2001) Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J. 15, 916-926.
35. Lei S., Czerwinska E., Cserwinski W., Walsh M. P. and MacDonald J. F. (2001) Regulation of NMDA receptor activity by F-actin and myosin light chain kinase. J. Neurosci. 21, 8464-8472.
36. 2+ channels expressed in Xenopus oocytes. J. Neurosci. 18, 6740-6747.
37. Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 7699-7710.
38. Milner H. E., Beliveau R. and Jarvis S. M. (1994) The in situ size of the dopamine transporter is a tetramer as estimated by radiation inactivation. Biochim. Biophys. Acta 1190, 185-187.
39. Nakanish S., Catt K. J. and Balla T. (1994) Inhibition of agonist-stimulated inositol 1,4,5-triphosphate production and calcium signaling by the myosin light chain kinase inhibitor, wortmannin. J. Biol. Chem. 269, 6528-6535.
40. Olanow C. W. (1993) A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444.
41. 3H]DA uptake and autoxidation in rat striatal slices. Exp. Neurol. 152, 88-94.
42. Park S. U., Ferrer J. V., Javitch J. A. and Kuhn D. M. (2002) Peroxynitrite inactivates the human dopamine transporter by modification of Cys342: potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 22, 4399-4405.
43. Saunders C., Ferrer J. V., Shi L., Chen J., Merrill G., Lamb M. E., Leeb-Lundberg L. M. F., Carvelli L., Javitch J. A. and Galli A. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. USA 97, 6850-6855.
44. Segel I. H. (1976) Biochemical Calculations, pp. 218-323. John Wiley & Sons: New York.
45. Shyue S. K., Tsai M. J., Liou J. Y., Willerson J. T. and Wu K. K. (2001) Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer. Circulation 103, 2090-2095.
46. 2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
47. Tan S., Sagara Y., Liu Y., Maher P. and Schubert D. (1998) The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 1423-1432.
48. Toews M. L., Waldo G. L., Harden T. K. and Perkins J. P. (1984) Relationship between an altered membrane form and a low affinity form of the β-adrenergic receptor occurring during catecholamine-induced desensitization: evidence for receptor internalization. J. Biol. Chem. 259, 11844-11850.
49. Torres G. E., Yao W. D., Mohn A. R., Quan H., Kim K. M., Levey A. I., Staudinger J. and Caron M. G. (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30, 121-134.
50. Trotti D., Rossi D., Gjesdal O., Levy L. M., Racagni G., Danbolt N. C. and Volterra A. (1996) Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271, 5976-5979.
51. Trotti D., Danbolt N. C. and Volterra A. (1998) Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 19, 328-334.
52. Trotti D., Rolfs A., Danbolt N. C., Brown R. H. Jr and Hediger M. (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2, 427-433.
53. 3H] noradrenaline uptake in PC12 cells through calmodulin-dependent kinases. Brain Res. 809, 155-164.
54. 3H] dopamine uptake in rat striatum: possible involvement of calmodulin-dependent kinases. J. Neurochem. 65, 2065-2071.
55. Ushio-Fukai M., Alexander R. W., Akers M., Yin Q., Fujio Y., Walsh K. and Griendling K. K. (1999) Reactive oxygen species mediated the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 274, 22699-22704.
56. Vaughan R. A., Huff R. A., Uhl G. R. and Kuhar M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 15541-15546.
57. Volterra A., Trotti D., Tromba C., Floridi S. and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
58. Vroegop S. M., Decker D. E. and Buxser S. E. (1995) Localization of damage induced by reactive oxygen species in cultured cells. Free Rad. Biol. Med. 18, 141-151.
59. Wang H. and Joseph J. A. (2000) Mechanisms of hydrogen peroxide-induced calcium dysregulation in PC12 cells. Free Rad. Biol. Med. 28, 1222-1231.
60. Wang J. B., Moriwaki A. and Uhl G. R. (1995) Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression. J. Neurochem. 64, 1416-1419.
61. Whitehead R. E., Ferrer J. V., Javitch J. A. and Justice J. B. (2001) Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J. Neurochem. 76, 1242-1251.
62. Yano H., Nakanishi S., Kimura K., Hanai N., Saitoh Y., Fukui Y., Nonomura Y. and Matsuda Y. (1993) Inhibition of histamine secretion by wortmannin through the blockade of phosphatidyl-inositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268, 25846-25856.
63. Zhang L., Coffey L. L. and Reith M. E. (1997) Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem. Pharmacol. 53, 667-688.
64. Zhu S. J., Kavanaugh M. P., Sonders M. S., Amara S. M. and Zahniser N. R. (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter in Xenopus oocytes. J. Pharmacol. Exp. Ther. 282, 1358-1356.